Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group

Biopreservation and Biobanking

Volumn 14, Issue 5, 2016, Pages 398-409

  Betsou, Fay ^a   Bulla, Alexandre ^b   Cho, Sang Yun ^c   Clements, Judith ^d   Chuaqui, Rodrigo ^e   Coppola, Domenico ^f   De Souza, Yvonne ^g   De Wilde, Annemieke ^h   Grizzle, William ⁱ   Guadagni, Fiorella ^j   Gunter, Elaine ^k   Heil, Stacey ^l   Hodgkinson, Verity ^m   Kessler, Joseph ⁿ   Kiehntopf, Michael ^o   Kim, Hee Sung ^p   Koppandi, Iren ^q   Shea, Katheryn ^r   Singh, Rajeev ^s   Sobel, Marc ^t   Somiari, Stella ^u   Spyropoulos, Demetri ^v   Stone, Mars ^w   Tybring, Gunnel ^x   Valyi Nagy, Klara ^y   Van Den Eynden, Gert ^z   Wadhwa, Lalita ^aa   more..

^a INTEGRATED BIOBANK OF LUXEMBOURG   (Luxembourg)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c National Biobank of Korea   (South Korea)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^e NATIONAL CANCER INSTITUTE   (United States)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h ANTWERP UNIVERSITY HOSPITAL   (Belgium)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j IRCCS SAN RAFFAELE PISANA   (Italy)

^k Specimen Solutions LLC   (United States)

^l Laboratory of Molecular and Cellular Biology of Hematopoiesis   (United States)

^m Cancer Council   (Australia)

ⁿ Medpace Reference Laboratories ^*  (United States)

^o JENA UNIVERSITY HOSPITAL   (Germany)

^p Chung Ang University College of Medicine   (South Korea)

^q Cellular Technology Ltd   (United States)

^r Precision for Medicine Inc   (United States)

^s HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^t American Society for Investigative Pathology   (United States)

^u WINDBER RESEARCH INSTITUTE   (United States)

^v MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^w BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^x KAROLINSKA INSTITUTE   (Sweden)

^y UNIVERSITY OF ILLINOIS   (United States)

^z GZA Hospitals St   (Belgium)

^aa BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

biological fluid; biospecimen; cells; qualification; quality control; tissue

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDYLPROLYL ISOMERASE; PROGESTERONE RECEPTOR; PROTEIN KINASE B; SUPEROXIDE DISMUTASE;

ASSAY; BIOBANK; BODY FLUID; BREAST CANCER; COLD ISCHEMIA; CONFERENCE PAPER; CYTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL RESEARCH; PRIORITY JOURNAL; QUALITY CONTROL; TISSUE SECTION; ANTIBODY SPECIFICITY; SPECIMEN HANDLING; STANDARDS;

BIOLOGICAL SPECIMEN BANKS; BIOMEDICAL RESEARCH; HUMANS; ORGAN SPECIFICITY; QUALITY CONTROL; SPECIMEN HANDLING;

EID: 84992135316     PISSN: 19475535     EISSN: 19475543     Source Type: Journal    
DOI: 10.1089/bio.2016.0018     Document Type: Conference Paper

References (53)

1. Cummings J, Raynaud F, Jones L, et al. Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs. Br J Cancer 2010;103:1313-1317.
2. Betsou F, Barnes R, Burke T, et al. Human biospecimen research: experimental protocol and quality control tools. Cancer Epidemiol Biomarkers Prev 2009;18:1017-1025.
3. Lehmann S, Guadagni F, Moore H, et al. Standard pre-analytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC). Biopreserv Biobank 2012;10:366-374.
4. Siest G, Henny J, Schiele F. References en Biologie Clin-ique. Paris: Elsevier;1990.
5. Ghnassia J-C. Echantillons Biologiques Phase Pre-analytique et Prelevements en Biologie Medicale. Paris: Elsevier;1998.
6. Belenky A, Smith A, Zhang B, et al. The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma. Clin Chim Acta 2004;340:163-172.
7. Williams KM, Williams AE, Kline LM, et al. Stability of serum alanine aminotransferase activity. Transfusion 1987;27: 431-433.
8. Gislefoss RE, Grimsrud TK, Morkrid L. Stability of selected serum proteins after long-term storage in the Janus Serum Bank. Clin Chem Lab Med 2009;47:596-603.
9. Kim W, Egan JM. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev 2008; 60:470-512.
10. Ramont L, Thoannes H, Volondat A, et al. Effects of hemolysis and storage condition on neuron-specific eno-lase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin Chem Lab Med 2005;43:1215-1217.
11. Breitbach S, Tug S, Helmig S, et al. Direct quantification of cell-free, circulating DNA from unpurified plasma. PLoS One 2014;9.
12. Nolan T, Hands RE, Ogunkolade W, et al. SPUD: a quantitative PCR assay for the detection of inhibitors in nucleic acid preparations. Anal Biochem 2006;351:308-310.
13. De Jongh R, Vranken J, Vundelinckx G, et al. The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor. Cytokine 1997; 9:696-701.
14. Lengelle J, Panopoulos E, Betsou F. Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum. Cytokine 2008;44:275-282.
15. Korse CM, Holdenrieder S, Zhi XY, et al. Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China. Clin Chim Acta 2015;438:388-395.
16. Trezzi J-P, Bulla A, Bellora C, et al. LacaScore: a novel plasma sample quality control tool based on ascorbic acid and lactic acid levels. Metabolomics 2016; in press.
17. Kamlage B, Maldonado SG, Bethan B, et al. Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. Clin Chem 2014;60:399-412.
18. Yi J, Kim C, Gelfand CA. Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma. J Proteome Res 2007;6: 1768-1781.
19. Marshall J, Kupchak P, Zhu W, et al. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J Proteome Res 2003;2:361-372.
20. Chong BH, Murray B, Berndt MC, et al. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 1994;83:1535-1541.
21. Thomas L. Haemolysis as influence and interference factor. Available at www.ifcc.org/ifccfiles/docs/130401002end.pdf (accessed March 30, 2016).
22. Carlebjork G, Blomback M, Akerblom O. Improvement of plasma quality as raw material for factor VIII:C concentrates. Storage of whole blood and plasma and interindi-vidual plasma levels of fibrinopeptide A. Vox Sang 1983; 45:233-242.
23. Betsou F, Roussel B, Guillaume N, et al. Long-term stability of coagulation variables: protein S as a biomarker for preanalytical storage-related variations in human plasma. Thromb Haemost 2009;101:1172-1175.
24. Berg KJ, Kristoffersen DT, Djoseland O, et al. Reference range of some enzymes and proteins in untimed overnight urine and their stability after freezing. Clin Chim Acta 1998;272:225-230.
25. Uchida K, Gotoh A. Measurement of cystatin-C and cre-atinine in urine. Clin Chim Acta 2002;323:121-128.
26. Poulsen K, Bahl JM, Tanassi JT, et al. Characterization and stability of transthyretin isoforms in cerebrospinal fluid examined by immunoprecipitation and high-resolution mass spectrometry of intact protein. Methods 2012;56:284- 292.
27. Hansson SF, Simonsen AH, Zetterberg H, et al. Cystatin C in cerebrospinal fluid and multiple sclerosis. Ann Neurol 2007;62:193-196; discussion 205.
28. Greco V, Pieragostino D, Piras C, et al. Direct analytical sample quality assessment for biomarker investigation: qualifying cerebrospinal fluid samples. Proteomics 2014;14: 1954-1962.
29. Tibble JA, Bjarnason I. Fecal calprotectin as an index of intestinal inflammation. Drugs Today (Barc) 2001;37:85- 96.
30. Ehrich M, Zoll S, Sur S, et al. A new method for accurate assessment of DNA quality after bisulfite treatment. Nucleic Acids Res 2007;35:e29.
31. Vermeulen J, De Preter K, Lefever S, et al. Measurable impact of RNA quality on gene expression results from quantitative PCR. Nucleic Acids Res 2011;39:e63.
32. Debey S, Schoenbeck U, Hellmich M, et al. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J 2004;4:193-207.
33. Benita Y, Kikuchi H, Smith AD, et al. An integrative ge-nomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hyp-oxia. Nucleic Acids Res 2009;37:4587-4602.
34. Curry CV. Differential Blood Count Medscape. Available at: http://emedicine.medscape.com/article/2085133-overview (accessed March 30, 2016).
35. Pinhel IF, Macneill FA, Hills MJ, et al. Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer. Breast Cancer Res 2010;12:R76.
36. Masood S, von Wasielewski R, Mengel M, et al. Influence of fixation, antibody clones, and signal amplification on steroid receptor analysis. Breast J 1998;4:33-40.
37. Yildiz-Aktas IZ, Dabbs DJ, Bhargava R. The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma. Mod Pathol 2012;25: 1098-1105.
38. Neumeister VM, Parisi F, England AM, et al. A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue. Lab Invest 2014;94:467-474.
39. Skold K, Svensson M, Norrman M, et al. The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: stathmin 2-20 and peptides as sample quality indicators. Proteomics 2007;7:4445-4456.
40. Ferrer I, Santpere G, Arzberger T, et al. Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe Study. J Neuropathol Exp Neurol 2007;66:35-46.
41. Scholz B, Skold K, Kultima K, et al. Impact of temperature dependent sampling procedures in proteomics and peptidomics-a characterization of the liver and pancreas post mortem degradome. Mol Cell Proteomics 2011;10.
42. Serizawa M, Yokota T, Hosokawa A, et al. The efficacy of uracil DNA glycosylase pretreatment in amplicon-based massively parallel sequencing with DNA extracted from archived formalin-fixed paraffin-embedded esophageal cancer tissues. Cancer Genet 2015;208:415-427.
43. van Beers EH, Joosse SA, Ligtenberg MJ, et al. A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer 2006;94:333-337.
44. Wang F, Wang L, Briggs C, et al. DNA degradation test predicts success in whole-genome amplification from diverse clinical samples. J Mol Diagn 2007;9:441-451.
45. Gajadhar AS, Johnson H, Slebos RJ, et al. Phosphotyrosine signaling analysis in human tumors is confounded by systemic ischemia-driven artifacts and intra-specimen heterogeneity. Cancer Res 2015;75:1495-1503.
46. Li J, Kil C, Considine K, et al. Intrinsic indicators for specimen degradation. Lab Invest 2013;93:242-253.
47. Dirks WG, Drexler HG. Authentication of scientific human cell lines: easy-to-use DNA fingerprinting. Methods Mol Biol 2005;290:35-50.
48. Jeon JP, Nam HY, Shim SM, et al. Sustained viral activity of Epstein-Barr virus contributes to cellular immortalization of lymphoblastoid cell lines. Mol Cells 2009;27:143-148.
49. Lowes LE, Hedley BD, Keeney M, et al. User-defined protein marker assay development for characterization of circulating tumor cells using the CellSearch" system. Cytometry A 2012;81:983-995.
50. McKenna KC, Beatty KM, Vicetti Miguel R, et al. Delayed processing of blood increases the frequency of activated CD11b+ CD15+ granulocytes which inhibit T cell function. J Immunol Methods 2009;341:68-75.
51. Evenson D, Jost L. Sperm chromatin structure assay is useful for fertility assessment. Methods Cell Sci 2000;22:169-189.
52. Bennett-Guerrero E, Veldman TH, Doctor A, et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci USA 2007;104:17063-17068.
53. Holme S, Sweeney JD, Sawyer S, et al. The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion 1997;37:12-17.